Article written by Newcastle MEP Jude Kirton-Darling after she met with EASL Scientific Committee member Dr Helen Louise Reeves, other NE hepatologists and EASL EU Director of Public Affairs, Fiona Godfrey in Newcastle, UK, recently.
Now 3346 members from 103 countries
EASL Governing Board
Prof. Markus Peck-Radosavljevic
Prof. Markus Peck-Radosavljevic

Markus Peck-Radosavljevic, MD, is Associate Professor of Medicine and Vice-Chairman at the Department of Gastroenterology and Hepatology at the Medizinische Universität Wien (MedUniWien), Austria. He is a fellow of the Austrian College of Physicians (Internal Medicine, Gastroenterology / Hepatology, Infectious Diseases, and Intensive Care Medicine) and member of several professional organisations including the American Association for the Study of Liver Disease (AASLD), the European Association for the Study of the Liver (EASL), the American Gastroenterologic Association (AGA), the Austrian Transplant Association, the Austrian Society for Infectious Diseases, and the Austrian Association for Gastroenterology and Hepatology. Prof. Peck is currently the Secretary General of the Austrian Association for Internal Medicine.

Prof. Peck started out his research in liver disease with the complications of portal hypertension and cirrhosis including the hematologic abnormalities. He has published several reports on thrombocytopenia and thrombopoietin in liver disease and liver transplantation and later more on the hematologic side effects of antiviral therapy in chronic hepatitis C. He has been co-investigator in trial of pegInterferon in liver transplant patients and principal investigator in trials of pegIFN in hemodialysis patients with chronic hepatitis C or combination antiviral therapy in HIV/HCV coinfected patients. 

For the last several years, he has been heading the Portal Hypertension as well as the HCC Study Group at the MedUniWien. Currently he is engaged in mostly clinical but also some basic research in advanced stage liver disease, including problems related to portal hypertension, viral hepatitis, and hepatocellular carcinoma, where he is conducting several clinical trials.

Prof. Markus Peck-Radosavljevic
Medizinische Universtät Wien
Abteilung Gastroenterologie & Hepatologie
Vienna, Austria

Tel: (+43) 1-40400 4744